Sociedad Americana de Hirudoterapia

Development and validation of interpretable machine learning models for predicting the risk of necrosis after finger replantation: A retrospective multicenter study

Research article published in Injury (2025)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Observational studySeguridad y control de infeccionesDong et al. · Injury, 2025

Abstract

INTRODUCTION: Digital necrosis (DN) is a critical postoperative complication following finger replantation surgery. This can necessitate additional surgical interventions that can adversely affect the patient's hand functionality, psychological well-being, and financial standing. The timely identification and management of the risk of post-replantation DN are thus crucial for enhancing patient outcomes. The objective of this study was to create and validate an easily understandable machine learning (ML) model for predicting the risk of DN following finger replantation surgery. PATIENTS AND METHODS: Data from 1579 patients who underwent finger replantation surgery at Suzhou Ruihua Orthopaedic Hospital between September 2018 and September 2023 were collected and divided into training and internal validation sets. Additionally, 293 data points from two other institutions were employed as independent external validation sets. Ten machine-learning methods, including Gradient Boosting Machine (GBM), were utilized for modeling. The performance of the model was assessed using the area under the receiver operating characteristic curve (AUC) and decision curve analysis (DCA). SHapley Additive exPlanation (SHAP) was utilized to provide both global and local interpretations of the final model. RESULTS: Nine indices, including the seniority of the doctor and the neutrophil count, were identified as independent predictors of DN. The GBM model showed optimal model with high predictive accuracy for DN risk in both the training set (AUC: 0.995) and the internal validation set (AUC: 0.978), which was confirmed using external validation (AUC: 0.983). The reliability and utility of the GBM model and the web-based computing platform were confirmed by DCA, calibration curve, accuracy, and sensitivity analyses. CONCLUSION: An interpretable machine-learning model based on complete blood counts and related inflammatory marker levels was constructed and validated to predict the likelihood of developing DN following finger replantation. This model can assist clinicians in the prompt identification of high-risk patients post-replantation, enabling timely intervention.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal ArticleMulticenter StudyValidation Study
Indexed MeSH termsHumansMachine LearningRetrospective StudiesReplantationMaleFemaleAdultFinger InjuriesNecrosisMiddle AgedPostoperative ComplicationsRisk Assessment

Resumen

Peer-reviewed research on safety and infection-control considerations relevant to leech therapy and anticoagulation. Indexed in PubMed and verified against the NCBI record.

Por qué esto importa para la hirudoterapia

Este estudio multicéntrico retrospectivo desarrolló y validó modelos interpretables de aprendizaje automático para predecir la necrosis digital (DN) tras la reimplantación de dedos, utilizando 1,579 pacientes para el entrenamiento/validación interna y 293 casos externos de otras dos instituciones; una Gradient Boosting Machine que utilizó el hemograma completo y marcadores inflamatorios alcanzó una alta discriminación (AUC aproximadamente 0.995 en entrenamiento, 0.978 interna, 0.983 externa), con nueve predictores que incluyen la antigüedad del médico y el recuento de neutrófilos. Es relevante para la hirudoterapia porque la necrosis digital por congestión venosa es el modo de fracaso preciso que la terapia con sanguijuelas se utiliza para prevenir en reimplantes comprometidos, por lo que una herramienta validada que identifique los dedos de alto riesgo podría ayudar a dirigir intervenciones oportunas, incluidas medidas adyuvantes, antes de que se pierda un reimplante. Advertencia honesta: este es un estudio retrospectivo de modelado predictivo; no evalúa la terapia con sanguijuelas, y los AUC muy altos reportados requieren una validación externa prospectiva y más amplia antes de su uso clínico.

Citación

Development and validation of interpretable machine learning models for predicting the risk of necrosis after finger replantation: A retrospective multicenter study.

Dong et al. · Injury, 2025

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.